在T2DM中绘制线粒体景观:从2003年到2023年的关键发现
Yi Tan1, Mingjun Liu1, Xinfeng Zhou1
1Departments of Acupuncture and Massage, Changchun University of Chinese Medicine, Changchun, Jilin, China.
Frontiers in endocrinology
|December 5, 2024
概括
本文献分析揭示了2型糖尿病 (T2DM) 线粒体研究的关键趋势. 它强调了人们日益关注线粒体功能障碍和T2DM病原体中的粒子动态.
科学领域:
- 生物医学研究生物医学研究
- 代谢障碍 代谢障碍 代谢障碍
- 线粒体生物学 线粒体生物学
背景情况:
- 2型糖尿病 (T2DM) 是一个重要的全球健康问题.
- 线粒体在T2DM的发展中起着至关重要的作用.
- 了解线粒体和T2DM之间的相互作用对于公共卫生至关重要.
研究的目的:
- 进行对2003-2023年线粒体和T2DM研究的文献分析.
- 确定关键的研究趋势,重点和新兴领域.
- 为未来在这一领域的研究提供基础.
主要方法:
- 在SCI-扩展数据库的文献搜索 (2003-2023年).
- 使用Vosviewer,CiteSpace和RStudio.com进行图书统计分析.
- 分析国家,机构,作者,期刊,参考文献和关键词.
主要成果:
- 发表了2,732篇文章;美国,中国和意大利是主要贡献者.
- 主要机构包括加利福尼亚大学系统和INSERM.
- 突出的研究主题包括线粒体功能障碍,骨肌肉变化和T2DM中的粒子动态.
结论:
- 这项研究成功地绘制了线粒体和T2DM的研究格局.
- 确定了关键领域和新兴趋势,为未来的研究方向提供了宝贵的见解.
- 这种分析有助于理解线粒体功能与T2DM之间的复杂关系.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...


